… Blurred vision in the NOV03 QID group, eye irritation in the NOV03 BID group, and eye
pain in the saline group were the only terms reported by more than 2% of subjects (2.6%–2.7%). …

… research was to investigate the efficacy and safety of a twice daily (BID) … safety and efficacy
of KPI-121 1% to vehicle in the treatment of subjects with postsurgical inflammation and pain …

… In a large dose-response phase 2 study, the efficacy and safety of 1% and 2% rebamipide
… and TBUT, foreign body sensation and eye pain scores were significantly improved in the …

… This study examined the safety and efficacy of a proprietary new eye drop formulation for …
-Dawley rats to study the efficacy and safety of the investigational compound that contained 20 …

… the efficacy … eye pain in the past 24 h on a scale of 0–10 at the visit where nortriptyline was
prescribed (termed “first visit” for the purposes of this study); 3) the average level of eye pain …

… the safety of and change from baseline of tear breakup time and visual analog pain scales in
dry eye … assessing global ocular pain severity, ocular pain frequency, and ocular pain in the …

… the safety and effectiveness of intranasal neurostimulation to promote tear production via the
nasolacrimal pathway in subjects with dry eye … The significant improvement in ocular pain …

… Eye irritation and eye pain were the most common TEAEs in the CsA CE 0.1% and vehicle …
Instillation site pain was the most frequently reported treatment-related ocular AE in SANSIKA …

… CyclASol showed efficacy, safety, and tolerability at 2 concentrations in moderate-to-severe …
in dry eye sufferers, was shown to have the most benefit from treatment. Excellent safety, …

… A composite responder efficacy endpoint (corneal fluorescein staining–Ocular Surface
Disease Index (CFS–OSDI) at month 6) was used to evaluate the efficacy of CsA CE in alleviating …